Does hepatitis C virus infection increase the risk of HIV disease progression?

被引：21

作者：

Rossi, SJ

Volberding, PA

Wright, TL

机构：

[1] Dept Vet Affairs Med Ctr, Med Serv, San Francisco, CA USA

[2] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 02期

关键词：

D O I：

10.1001/jama.288.2.241

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：241 / 243

页数：3

共 18 条

[1]

Aceti A, 2002, J ACQ IMMUN DEF SYND, V29, P41, DOI 10.1097/00042560-200201010-00005

[2] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].

Alter, MJ ;

Kruszon-Moran, D ;

Nainan, OV ;

McQuillan, GM ;

Gao, FX ;

Moyer, LA ;

Kaslow, RA ;

Margolis, HS .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562

[3]

BARTLETT JG, 2001, 8 C RETR OPP INF FEB

[4] Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy [J].

Benhamou, Y ;

Di Martino, V ;

Bochet, M ;

Colombet, G ;

Thibault, V ;

Liou, A ;

Katlama, C ;

Poynard, T .

HEPATOLOGY, 2001, 34 (02) :283-287

[5] Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].

Benhamou, Y ;

Bochet, M ;

Di Martino, V ;

Charlotte, F ;

Azria, F ;

Coutellier, A ;

Vidaud, M ;

Bricaire, F ;

Opolon, P ;

Katlama, C ;

Poynard, T .

HEPATOLOGY, 1999, 30 (04) :1054-1058

[6] Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection [J].

Bica, I ;

McGovern, B ;

Dhar, R ;

Stone, D ;

McGowan, K ;

Scheib, R ;

Snydman, DR .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :492-497

[7]

DERBRINKER M, 2000, AIDS, V14, P2895

[8] Pegylated (40 kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin:: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study [J].

Fried, MW ;

Shiffman, ML ;

Reddy, RK ;

Smith, C ;

Marino, G ;

Goncales, F ;

Haeussinger, D ;

Diago, M ;

Carosi, G ;

Zarski, JP ;

Hoffman, J ;

Yu, J .

GASTROENTEROLOGY, 2001, 120 (05) :A55-A55

[9] Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study [J].

Greub, G ;

Ledergerber, B ;

Battegay, M ;

Grob, P ;

Perrin, L ;

Furrer, H ;

Burgisser, P ;

Erb, P ;

Boggian, K ;

Piffaretti, JC ;

Hirschel, B ;

Janin, P ;

Francioli, P ;

Flepp, M ;

Telenti, A .

LANCET, 2000, 356 (9244) :1800-1805

[10]

HARE CB, 2002, 9 C RETR OPP INF FEB

← 1 2 →